FDA: Unapproved Genetic Tests Claim to Predict Drug Response
The Food and Drug Administration (FDA) issued a warning to Inova Genomics Laboratory for the illegal marketing of pharmacogenetic tests for predicting medication response to antidepressants, opioids, cancer therapy, anesthesia, and diabetes treatments. The warning letter describes how Inova’s MediMap tests are being falsely marketed to predict drug response to aid in making treatment decisions…